Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Eyenovia ( (EYEN) ).
Eyenovia, Inc. has announced a $1.9 million registered direct offering, selling common stock and warrants to an institutional investor. The proceeds are intended for working capital, corporate purposes, and advancing their Optejet device. The offering, facilitated by Chardan Capital Markets, is poised to enhance Eyenovia’s market presence in ophthalmic technology. Investors are keen on the potential strategic partnerships and the innovative Gen-2 Optejet device development.
For detailed information about EYEN stock, go to TipRanks’ Stock Analysis page.